HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slash heart attack and stroke risk in thousands
Disease control OngoingThis large, late-stage study is testing whether a new oral drug called MK-0616 can help prevent serious heart and blood vessel problems in people at high risk. About 14,550 adults who are already taking cholesterol-lowering medication will receive either the new drug or a placebo…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Two-Year safety watch for cholesterol drug
Disease control OngoingThis study is monitoring the long-term safety of Leqvio, a cholesterol-lowering injection, in real-world medical practice in Japan. It will follow 585 patients with high cholesterol or inherited high cholesterol conditions for up to two years after starting treatment. The main go…
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC